Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).

Bibliografiske detaljer
Main Authors: Maini, R, Taylor, P, Pavelka, K, Emery, P, Szechinski, J, Balint, G, Broll, J, Grp, C
Format: Conference item
Udgivet: 2003
_version_ 1826299014297944064
author Maini, R
Taylor, P
Pavelka, K
Emery, P
Szechinski, J
Balint, G
Broll, J
Grp, C
author_facet Maini, R
Taylor, P
Pavelka, K
Emery, P
Szechinski, J
Balint, G
Broll, J
Grp, C
author_sort Maini, R
collection OXFORD
description
first_indexed 2024-03-07T04:55:28Z
format Conference item
id oxford-uuid:d6750948-58a6-4ef3-abca-46f737d45318
institution University of Oxford
last_indexed 2024-03-07T04:55:28Z
publishDate 2003
record_format dspace
spelling oxford-uuid:d6750948-58a6-4ef3-abca-46f737d453182022-03-27T08:33:34ZEfficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:d6750948-58a6-4ef3-abca-46f737d45318Symplectic Elements at Oxford2003Maini, RTaylor, PPavelka, KEmery, PSzechinski, JBalint, GBroll, JGrp, C
spellingShingle Maini, R
Taylor, P
Pavelka, K
Emery, P
Szechinski, J
Balint, G
Broll, J
Grp, C
Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
title Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
title_full Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
title_fullStr Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
title_full_unstemmed Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
title_short Efficacy of IL-6 receptor antagonist Mra in rheumatoid arthritis patients with an incomplete response to methotrexate (CHARISMA).
title_sort efficacy of il 6 receptor antagonist mra in rheumatoid arthritis patients with an incomplete response to methotrexate charisma
work_keys_str_mv AT mainir efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma
AT taylorp efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma
AT pavelkak efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma
AT emeryp efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma
AT szechinskij efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma
AT balintg efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma
AT brollj efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma
AT grpc efficacyofil6receptorantagonistmrainrheumatoidarthritispatientswithanincompleteresponsetomethotrexatecharisma